Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
584.75
|
|
Change (%)
|
1.45 (0.25%)
|
|
Best Buy (RS)
|
582.65(x34)
|
|
Best Sell (RS)
|
583.3(x16)
|
|
Today's Range (RS)
|
582.40
-
589.00
|
|
52-Week Range (RS)
|
412.05
-
621.10
|
|
Beta (1 Year)
|
1.33
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Granules India subsidiary completes USFDA inspection at Hyderabad facility |
| Granules India schedules board meeting |
| Granules Consumer Health completes USFDA inspection |
| Granules inaugurates two new Centres of Excellence at IIT Hyderabad |
| Granules India consolidated net profit rises 34.33% in the September 2025 quarter |
| Granules India standalone net profit rises 191.40% in the September 2025 quarter |
| Granules Life Sciences receives USFDA approval for its Hyderabad unit |
| Granules India's Hyderabad-based facility gets first U.S. FDA approval |
| Granules India Ltd - Granules India Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
| Granules Pharmaceuticals Inc. concludes USFDA inspection |
|
|
|
| Incoporation Year : 1991 |
| Chairman : C Krishna Prasad |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Granules India Ltd
15th Floor Granules Tower,
Botanical Garden Road Kondapur,
Hyderabad,
Telangana-500084 |
Phone:91-40-69043500
Fax:91-40-23115145 |
| E-Mail : investorrelations@granulesindia.com; mail@granules |
| URL : http://www.granulesindia.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
12-Dec-2025 |
574.50 |
1.53 |
| 1Month |
19-Nov-2025 |
553.85 |
5.32 |
| 3Month |
19-Sep-2025 |
543.00 |
7.42 |
| 6Month |
19-Jun-2025 |
480.40 |
21.42 |
| 1Year |
19-Dec-2024 |
600.20 |
-2.82 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Aditya Birla SL Value Fund |
2.13 |
135.76 |
| Edelweiss Balanced Advantage |
0.92 |
122.88 |
| Old Bridge Focused Fund |
3.85 |
87.98 |
| Aditya Birla SL Small Cap Fund |
1.22 |
61.54 |
| Tata Aggressive Hybrid Fund |
1.47 |
61.17 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,754.35 |
0.53 |
1,910.00 |
1,547.25 |
418,707.95 |
| Cipla Ltd |
1,521.00 |
0.26 |
1,672.20 |
1,310.05 |
122,538.89 |
| Dr Reddys Laboratories Ltd |
1,281.60 |
0.21 |
1,404.60 |
1,025.90 |
106,740.88 |
| Lupin Ltd |
2,123.50 |
-0.10 |
2,403.45 |
1,774.00 |
97,101.72 |
| Zydus Lifesciences Ltd |
921.80 |
0.21 |
1,059.00 |
797.05 |
92,558.43 |
|
|
|
|